journal article·2026-05

A novel fluorescent probe for real-time in vivo imaging of LACTB activity in acute lung injury

Ya-Hui Zhou, Ru Yan, Kai Wang, Hong-Xia Xiang, Zhong-Yuan Cheng, Wei-Lai Jin

Dyes and Pigments· Volume 248
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Molecular Sensors and Ion Detection · Immune Response and Inflammation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Idiopathic pulmonary fibrosis10.1016/S0140-6736(17)30866-8 ↗
2. PD-1/PD-L1 pathway mediates the alleviation of pulmonary fibrosis by human mesenchymal stem cells in humanized mice10.1165/rcmb.2017-0326OC ↗
3. Organ-on-a-chip systems for modeling pathological tissue morphogenesis associated with fibrosis and cancer10.1021/acsbiomaterials.0c01089 ↗
4. Insights into the pathogenesis of pulmonary fibrosis from genetic diseases10.1165/rcmb.2021-0557TR ↗
5. Pulmonary fibrosis: pathogenesis and therapeutic strategies10.1002/mco2.744 ↗
6. Idiopathic pulmonary fibrosis:pathophysiological data
7. Clinical course and prediction of survival in idiopathic pulmonary fibrosis10.1164/rccm.201006-0894CI ↗
8. Fibrogenic disorders in human diseases: from inflammation to organ dysfunction10.1021/acs.jmedchem.8b00294 ↗
9. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid10.1172/JCI110823 ↗
10. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management10.1164/rccm.2009-040GL ↗
11. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American thoracic society (ATS), and the european respiratory society (ERS)10.1164/ajrccm.161.2.ats3-00 ↗
12. This joint statement of the american thoracic society (ATS), and the european respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive committee, June 2001
13. Computed tomographic biomarkers in idiopathic pulmonary fibrosis. The future of quantitative analysis10.1164/rccm.201803-0444PP ↗
14. Quantitative lung ultrasound spectroscopy applied to the diagnosis of pulmonary fibrosis: the first clinical study10.1109/TUFFC.2020.3012289 ↗
15. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models10.1126/scitranslmed.aaf4696 ↗
16. Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets10.1021/acs.jmedchem.6b00935 ↗
17. Idiopathic pulmonary fibrosis (IPF): an overview10.3390/jcm7080201 ↗
18. Novelties in imaging in pulmonary fibrosis and nodules. A narrative review10.1016/j.pulmoe.2019.09.009 ↗
19. New developments in imaging idiopathic pulmonary fibrosis with hyperpolarized xenon magnetic resonance imaging10.1097/RTI.0000000000000392 ↗
20. Recent advances in fluorescence imaging of pulmonaryfibrosis in animal models10.3389/fmolb.2021.773162 ↗
21. Pathogenesis of pneumonia and acute lung injury10.1042/CS20210879 ↗
22. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries10.1001/jama.2016.0291 ↗
23. Acute lung injury - from pathophysiology to treatment
24. Oxidative stress and inflammation in acute and chronic lung injuries10.3390/antiox12030548 ↗
25. Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury10.1016/j.ccc.2021.05.003 ↗
26. Glycolysis and acute lung injury: a review
27. The pivotal role of LACTB in the process of cancer development10.3390/ijms26031279 ↗
28. Unveiling the function of the mitochondrial filament-forming protein LACTB in lipid metabolism and cancer10.3390/cells11101703 ↗
29. LACTB suppresses carcinogenesis in lung cancer and regulates the EMT pathway10.3892/etm.2022.11172 ↗
30. CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1α-mediated lactate production10.1093/jmcb/mjae021 ↗
31. Regulation of macrophage activation by lactylation in lung disease10.3389/fimmu.2024.1427739 ↗
32. Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant pseudomonas aeruginosa in a rat model of chronic lung infection10.1034/j.1600-0463.2002.1101207.x ↗
33. High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in pseudomonas aeruginosa biofilms10.1128/AAC.01393-12 ↗
34. Strategic approaches to overcome resistance against gram-negative pathogens using β-Lactamase Inhibitors and β-Lactam enhancers: activity of three novel diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 423410.1021/acs.jmedchem.8b00091 ↗
35. Recent progress in chromogenic and fluorogenic chemosensors for hypochlorous acid10.1039/C6AN00158K ↗
36. Fluorescent detection of hypochlorous acid from turn-on to FRET-based ratiometry by a HOCl-mediated cyclization reaction10.1002/chem.201101918 ↗
37. A highly specific and ultrasensitive near-infrared fluorescent probe for imaging basal hypochlorite in the mitochondria of living cells10.1016/j.bios.2018.02.023 ↗
38. A fast-responsive mitochondria-targeted fluorescent probe detecting endogenous hypochlorite in living RAW 264.7 cells and nude mouse10.1039/C4CC07411D ↗
39. Development of targetable two-photon fluorescent probes to image hypochlorous Acid in mitochondria and lysosome in live cell and inflamed mouse model10.1021/jacs.5b00042 ↗